Personalis Inc Asset Turnover Ratio (PSNL), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Personalis Inc   (NASDAQ: PSNL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Personalis Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Personalis Inc asset turnover ratio, the ability of Personalis Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.22 in the third quarter (Sep 30 2026), yet the ratio remained below the average, as PSNL's position remain challenging.

Within sector 21 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 1787 to 2645.

Asset Turnover Ratio Definition



PSNL Asset Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Asset Change 62.19 % 59.27 % 19.06 % 30.49 % 8.65 %
Y / Y Revenue Change 76.59 % 29.96 % -24.91 % 3.24 % -43.62 %
Asset Turnover Ratio (TTM) 0.22 0.21 0.22 0.25 0.27
PSNL's Total Ranking # 2645 # 1787 # 2459 # 1578 #
Seq. Asset Change -4.4 % 26.61 % -2.62 % 37.61 % -6.12 %
Seq. Revenue Change 14.49 % 44.5 % -10.8 % 19.66 % -15.74 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 22
Healthcare Sector # 395
Overall Market # 2645

Asset Turnover Ratio Statistics
High Average Low
15.88 7.94 4.49
(Jun 30 2020)   (Mar 31 2023)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Rigel Pharmaceuticals Inc  0.56 $ 288.213  Millions$ 515.786  Millions
Stryker Corp  0.56 $ 26,300.000  Millions$ 47,328.000  Millions
Mannkind Corporation  0.55 $ 413.370  Millions$ 747.876  Millions
Icu Medical Inc  0.55 $ 2,183.556  Millions$ 3,994.839  Millions
Emergent Biosolutions Inc   0.55 $ 649.100  Millions$ 1,187.750  Millions
Bionano Genomics Inc   0.54 $ 31.085  Millions$ 58.068  Millions
Integer Holdings Corporation  0.54 $ 1,825.122  Millions$ 3,409.958  Millions
Vanda Pharmaceuticals Inc   0.53 $ 229.278  Millions$ 429.317  Millions
Ge Healthcare Technologies Inc   0.53 $ 19,878.000  Millions$ 37,412.000  Millions
Transmedics Group Inc   0.53 $ 727.650  Millions$ 1,371.382  Millions
Orthopediatrics Corp  0.52 $ 263.665  Millions$ 507.824  Millions
Cryo cell International Inc   0.51 $ 31.127  Millions$ 61.406  Millions
Johnson and Johnson  0.50 $ 99,335.000  Millions$ 199,647.500  Millions
Syndax Pharmaceuticals Inc   0.48 $ 289.431  Millions$ 599.674  Millions
Abbvie Inc   0.48 $ 66,014.000  Millions$ 138,304.500  Millions
Zevra Therapeutics Inc   0.48 $ 140.548  Millions$ 294.899  Millions
Boston Scientific Corporation  0.47 $ 21,070.000  Millions$ 44,675.250  Millions
Organon and Co   0.47 $ 6,111.000  Millions$ 13,110.500  Millions
Clearpoint Neuro Inc   0.47 $ 45.493  Millions$ 97.658  Millions
Abbott Laboratories  0.47 $ 48,229.000  Millions$ 103,651.000  Millions
Integra Lifesciences Holdings Corp  0.47 $ 1,656.786  Millions$ 3,562.754  Millions
Vertex Pharmaceuticals Inc  0.46 $ 12,951.600  Millions$ 28,071.750  Millions
Pacific Health Care Organization Inc  0.46 $ 6.368  Millions$ 13.927  Millions
Alkermes Plc   0.45 $ 1,753.599  Millions$ 3,893.429  Millions
Verastem Inc   0.44 $ 100.296  Millions$ 227.600  Millions
Bausch Health Companies Inc   0.44 $ 11,113.000  Millions$ 25,285.500  Millions
Ars Pharmaceuticals Inc   0.44 $ 122.136  Millions$ 279.051  Millions
Butterfly Network Inc   0.43 $ 123.715  Millions$ 288.356  Millions
Lemaitre Vascular Inc   0.42 $ 269.938  Millions$ 635.449  Millions
Aurinia Pharmaceuticals Inc   0.42 $ 321.738  Millions$ 773.387  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.